-
Patient-Reported Outcome (PRO)
“What matters is this – will it help patients?” ~ Bill Cook Introduction To ensure that patients...
-
The Impact of GCP R3 on Your Trial Master File
Introduction The third revision (R3) of the International Council for Harmonisation (ICH) Good Clinical Practice (GCP) was...
-
5 Main Components of a MDR Clinical Evaluation Report (CER)
To comply with the European Union Medical Device Regulation (MDR), medical device manufacturers are required to conduct...
-
Deviations in Medical Device Clinical Studies
Introduction During the conduct of a study, there may be instances where the study protocol is not...
-
Strategizing Biocompatibility Evaluation in Changing Manufacturing Environments: When do you Approach Subject Matter Experts?
In a dynamic manufacturing environment, changes are inevitable. Ensuring medical device safety is very crucial, particularly when...
-
Developing a Quality System / Standard Operating Procedures for Conducting Medical Device Clinical Trials
Introduction The development of quality system procedures or standard operating procedures (SOPs) for conducting clinical trials of...
-
Surface Morphology: A Case Study On Implantation Endpoint
In a previous blog post, we highlighted the essential role of surface characterization in ensuring the biocompatibility...
-
A Brief History of the Development of Clinical Research Principals, Guidelines, and Regulations
Hippocratic Oath The Hippocratic Oath was likely written between the 5th and 3rd centuries BCE. Its purpose...
-
5 Aspects of Device Clinical Study Close-Out
A clinical study process that is often underappreciated is close-out. Regardless if the study was completed or...
-
Completing clinical study enrollment and what’s next
Great job on completing enrollment! Reaching this major milestone is a big accomplishment as it marks the...
-
Key Takeaways from the FDA Draft Guidance on Chemical Analysis for Biocompatibility Assessment – Part 2 of 2
Within the last five years, there has been significant advancement in chemical analysis and toxicological risk assessment...
-
Key Takeaways from the FDA Draft Guidance on Chemical Analysis for Biocompatibility Assessment – Part 1 of 2
Within the last five years, there has been significant advancement in chemical analysis and toxicological risk assessment...
OUR COMMITMENT
We are committed to consistently performing services with high quality, that deliver exceptional results, and add value to the client’s business.
For client surveys sent in 2024, we received ratings of 4.98/5 points (13).